🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06587971
Recruiting Not applicable

Intensive Treatment on Periodontitis in Aortic Stenosis

NCT06587971 · tracked via the Priya Life Science China tracker
Sponsor
China National Center for Cardiovascular Diseases
Phase
Not applicable
Started
2023-05-10
Last updated
2024-09-19

Condition(s) studied

Aortic Valve StenosisPeriodontitis

Investigational drug(s) / intervention(s)

Standard periodontal treatment protocolOral hygiene education

Standard periodontal treatment protocol: Administering standard treatments for chronic periodontitis according to the current guidelines, including supragingival scaling, subgingival scaling, root planing, and periodontal flap surgery.

Oral hygiene education: Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Study summary

The goal of this clinical trial is to determine if standardized periodontal therapy can effectively slow the progression of aortic valve stenosis in adult patients diagnosed with moderate aortic valve stenosis and coexisting gingivitis or mild-to-moderate periodontitis.

The main questions it aims to answer are: Can periodontal therapy slow the progression of aortic valve stenosis? Is chronic periodontitis an independent risk factor for the accelerated progression of aortic valve stenosis? Researchers will compare a group of patients receiving standardized periodontal therapy to a control group receiving only oral hygiene education to see if periodontal treatment results in a slower progression of aortic valve stenosis.

Participants will undergo initial screening to confirm eligibility based on aortic valve peak velocity and periodontal status. They will then be randomly assigned to either the treatment group, which will receive comprehensive periodontal therapy, or the control group, which will receive only oral hygiene education. Participants will be followed up regularly over a 36-month period, with assessments including echocardiograms to monitor the progression of aortic valve stenosis, periodontal examinations to assess oral health status, and blood tests to measure relevant serum biomarkers. The study will also track any cardiovascular events and adverse events related to the interventions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Aged 18 years or older. * Aortic valve peak velocity (Vmax) between 3.0 and 3.9 m/s. * Diagnosis of aortic valve stenosis identified as degenerative aortic valve stenosis. * Presence of gingivitis or mild-to-moderate periodontitis confirmed by periodontal probing or panoramic dental radiography. * Willingness to participate in the study and signing of informed consent. Exclusion Criteria: * End-stage renal disease with eGFR \< 15 ml/min/1.73m² (according to the Cockcroft \& Gault formula). * Pregnant, breastfeeding, and women of childbearing age (except those with effective contraception). * Factors that may affect study follow-up or adherence to periodontal therapy. * Patients unwilling or unable to undergo comprehensive periodontal treatment. * Patients who do not consent to participate in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
China National Center for Cardiovascular Diseases Beijing Beijing Municipality Recruiting

More China National Center for Cardiovascular Diseases trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06587971 on ClinicalTrials.gov ↗ ← All trials in China